225 related articles for article (PubMed ID: 34725216)
1. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment.
Inagaki FF; Kano M; Furusawa A; Kato T; Okada R; Fukushima H; Takao S; Okuyama S; Choyke PL; Kobayashi H
Cancer Sci; 2024 Apr; ():. PubMed ID: 38671582
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared photoimmunotherapy and anti-cancer immunity.
Nakajima K; Ogawa M
Int Immunol; 2024 Feb; 36(2):57-64. PubMed ID: 37843836
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Effectiveness of IgG Antibody versus F(ab')
Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
[TBL] [Abstract][Full Text] [Related]
5. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
Fukushima H; Furusawa A; Kato T; Wakiyama H; Takao S; Okuyama S; Choyke PL; Kobayashi H
Mol Cancer Ther; 2023 Oct; 22(10):1215-1227. PubMed ID: 37461129
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
8. [Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation].
Kato T; Noma K; Furusawa A; Kobayashi H; Fujiwara T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1361-1363. PubMed ID: 38303275
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
[TBL] [Abstract][Full Text] [Related]
10. Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.
Sato K; Nagaya T; Nakamura Y; Harada T; Choyke PL; Kobayashi H
Oncotarget; 2015 Aug; 6(23):19747-58. PubMed ID: 25992770
[TBL] [Abstract][Full Text] [Related]
11. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Oncoimmunology; 2022; 11(1):2019922. PubMed ID: 35003897
[TBL] [Abstract][Full Text] [Related]
12. Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy.
Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Maruoka Y; Choyke PL; Kobayashi H
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322807
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
[TBL] [Abstract][Full Text] [Related]
15. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
[TBL] [Abstract][Full Text] [Related]
16. Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications.
Paraboschi I; Turnock S; Kramer-Marek G; Musleh L; Barisa M; Anderson J; Giuliani S
Crit Rev Oncol Hematol; 2021 May; 161():103325. PubMed ID: 33836238
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate.
Mitsunaga M; Nakajima T; Sano K; Choyke PL; Kobayashi H
Bioconjug Chem; 2012 Mar; 23(3):604-9. PubMed ID: 22369484
[TBL] [Abstract][Full Text] [Related]
18. Near infrared photoimmunotherapy for cancers: A translational perspective.
Maruoka Y; Wakiyama H; Choyke PL; Kobayashi H
EBioMedicine; 2021 Aug; 70():103501. PubMed ID: 34332294
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model.
Yasui H; Nishinaga Y; Taki S; Takahashi K; Isobe Y; Shimizu M; Koike C; Taki T; Sakamoto A; Katsumi K; Ishii K; Sato K
EBioMedicine; 2021 May; 67():103372. PubMed ID: 33993055
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer.
Fukushima H; Takao S; Furusawa A; Valera Romero V; Gurram S; Kato T; Okuyama S; Kano M; Choyke PL; Kobayashi H
Cancer Lett; 2024 Mar; 585():216606. PubMed ID: 38272345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
